Abstract:
Activated nucleoside derivatives formed in situ of general formula (I) in which one of R and R is R and the other is -P(R2)OR , wherein R is a substituted arylcarbonyl group, R is R O or R , R is a hydroxyl-protecting group and B is a purine or pyrimidine base. Particularly preferred are those compounds wherein R is 2,4-dinitrophenylcarbonyl. The compounds of general formula (I) are prepared using the corresponding carboxylic acids; these acids are generally more soluble in acetonitrile (for example, to the extent of 1.5 M for 2,4-dinitrobenzoic acid) and work as activators at lower concentrations. The compounds of general formula (I) may be employed in conventional coupling reactions (for example, solid phase synthesis) to prepare oligonucleotides which are indistinguishable from those prepared using the heretofore-known tetrazole-activated nucleoside intermediates.
Abstract:
Deoxyribonucleotide and ribonucleotide derivatives of general formula (I), wherein R represents -CR'R"-Ar, in which Ar is selected from the group consisting of unsubstituted or substituted aryl (as hereinafter defined) and R' and R" are independently selected from the group consisting of hydrogen and lower alkyl; one of -R and R is a hydroxyl-protecting group and the other is a group suitable for synthesis of polynucleotides or for attachment of the nucleotide to a solid support; R is selected from the group consisting of hydrogen, -OH and protected hydroxyl; and B represents a divalent radical corresponding to a purine or pyrimidine base. When synthesis is carried out using these derivatives, the deprotection procedure is reduced to an essentially instantaneous process. The derivatives have acceptable shelf life and are very stable to conventional DNA synthesis conditions. Particularly preferred are those compounds wherein Ar is mono- and dihalo-substituted phenyl.
Abstract:
Universal solid support oligonucleotide synthesis reagents, oligonucleotide synthesis processes, and reagents for cleaving oligonucleotides from solid supports are disclosed. Oligonucleotide synthesis reagents have the following general formula: SS - R - O - R wherein SS is a solid support; R is (a), (b) or (c), where R is hydrogen or alkyl and R is a phosphate protecting group; and R is a ring moiety having vicinal groups -XR and -YR wherein each of X and Y is independently selected from the group consisting of O, S and NH and one of R and R is a blocking moiety and the other is hydrogen or a hydroxy protecting group. Oligonucleotide cleaving reagents include methylamine and/or ammonium hydroxide and trimethylamine.
Abstract translation:公开了通用固体支持寡核苷酸合成试剂,寡核苷酸合成方法和用于从固体支持物切割寡核苷酸的试剂。 寡核苷酸合成试剂具有以下通式:SS-R 6 -O-R 3其中SS是固体支持物; R 6是(a),(b)或(c),其中R 5是氢或烷基,R 4是磷酸酯保护基; 并且R 3是具有连位-XR 1和-YR 2的环部分,其中X和Y各自独立地选自O,S和NH以及R 1和 R 2是封端部分,另一个是氢或羟基保护基团。 寡核苷酸切割试剂包括甲胺和/或氢氧化铵和三甲胺。
Abstract:
Disclosed herein are protecting groups for exocyclic amino groups of the base cytosine for use in the synthesis of oligonucleotides and oligonucleoside phosphorothioates, the protecting groups being represented by the formula: -CO-(CH2)0-9-CH3. In a particularly preferred embodiment, the base cytosine is protected with acetyl (-CO-CH3), and the oligonucleotide or oligonucleoside phosphorothioate incorporating the protected cytosine is subjected to a cleavage/deprotection reagent comprising methylamine and ammonia.
Abstract:
Activated nucleoside derivatives formed in situ of general formula (I) in which one of R?A and RB is R3¿ and the other is -P(R¿2)OR?1, wherein R1 is a substituted arylcarbonyl group, R?2 is R4O or R5, R3¿ is a hydroxyl-protecting group and B is a purine or pyrimidine base. Particularly preferred are those compounds wherein R1 is 2,4-dinitrophenylcarbonyl. The compounds of general formula (I) are prepared using the corresponding carboxylic acids; these acids are generally more soluble in acetonitrile (for example, to the extent of 1.5 M for 2,4-dinitrobenzoic acid) and work as activators at lower concentrations. The compounds of general formula (I) may be employed in conventional coupling reactions (for example, solid phase synthesis) to prepare oligonucleotides which are indistinguishable from those prepared using the heretofore-known tetrazole-activated nucleoside intermediates.
Abstract:
Universal solid support oligonucleotide synthesis reagents, oligonucleotide synthesis processes, and reagents for cleaving oligonucleotides from solid supports are disclosed. Oligonucleotide synthesis reagents have the following general formula: SS - R6 - O - R3 wherein SS is a solid support; R6 is (a), (b) or (c), where R5 is hydrogen or alkyl and R4 is a phosphate protecting group; and R3 is a ring moiety having vicinal groups -XR1 and -YR2 wherein each of X and Y is independently selected from the group consisting of O, S and NH and one of R?1 and R2¿ is a blocking moiety and the other is hydrogen or a hydroxy protecting group. Oligonucleotide cleaving reagents include methylamine and/or ammonium hydroxide and trimethylamine.
Abstract:
Deoxyribonucleotide and ribonucleotide derivatives of general formula (I), wherein R1 represents -CR'R'-Ar, in which Ar is selected from the group consisting of unsubstituted or substituted aryl (as hereinafter defined) and R' and R' are independently selected from the group consisting of hydrogen and lower alkyl; one of -R?2 and R3¿ is a hydroxyl-protecting group and the other is a group suitable for synthesis of polynucleotides or for attachment of the nucleotide to a solid support; R4 is selected from the group consisting of hydrogen, -OH and protected hydroxyl; and B represents a divalent radical corresponding to a purine or pyrimidine base. When synthesis is carried out using these derivatives, the deprotection procedure is reduced to an essentially instantaneous process. The derivatives have acceptable shelf life and are very stable to conventional DNA synthesis conditions. Particularly preferred are those compounds wherein Ar is mono- and dihalo-substituted phenyl.